One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Reflections on a contemporary European tragedy
Iain B McInnes, Annamaria Iagnocco, Daniel Aletaha, Xenofon Baraliakos, Johannes WJ Bijlsma, Elsa F Mateus, Zoltan Szekanecz, Theodora P M Vliet Vlieland, Josef S Smolen
doi : 10.1136/annrheumdis-2022-222652
June 2022 - Volume 81 - 6
EULAR 75-year anniversary: commentaries on key ARD papers from 1947
Tore K Kvien
Treatment of lupus: more options after a long wait
Myrto Kostopoulou, Antonis Fanouriakis, George Bertsias, Dimitrios T Boumpas
In the shadow of antibodies: how T cells defend against COVID-19
David S Pisetsky, Kevin L Winthrop
EULAR points to consider for the use of imaging to guide interventional procedures in patients with rheumatic and musculoskeletal diseases (RMDs)
Christian Dejaco, Pedro M Machado, Francesco Carubbi, Philipp Bosch, Lene Terslev, Giorgio Tamborrini, Luca Maria Sconfienza, Carlo Alberto Scirè, Sebastian Ruetten, Jef van Rompay, Fabian Proft, Costantino Pitzalis, Marina Obradov, Rikke Helene Moe, Vasco V Mascarenhas, Clara Malattia, Andrea Sabine Klauser, Alison Kent, Lennart Jans, Wolfgang Hartung, Hilde Berner Hammer, Christina Duftner, Peter V Balint, Alessia Alunno, Xenofon Baraliakos
EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus erythematosus and antiphospholipid syndrome
George C Drosos, Daisy Vedder, Eline Houben, Laura Boekel, Fabiola Atzeni, Sara Badreh, Dimitrios T Boumpas, Nina Brodin, Ian N Bruce, Miguel �ngel González-Gay, Søren Jacobsen, György Kerekes, Francesca Marchiori, Chetan Mukhtyar, Manuel Ramos-Casals, Naveed Sattar, Karen Schreiber, Savino Sciascia, Elisabet Svenungsson, Zoltan Szekanecz, Anne-Kathrin Tausche, Alan Tyndall, Vokko van Halm, Alexandre Voskuyl, Gary J Macfarlane, Michael M Ward, Michael T Nurmohamed, Maria G Tektonidou
EULAR points to consider when analysing and reporting comparative effectiveness research using observational data in rheumatology
Delphine Sophie Courvoisier, Kim Lauper, Joanna Kedra, Maarten de Wit, Bruno Fautrel, Thomas Frisell, Kimme L Hyrich, Florenzo Iannone, Pedro M Machado, Lykke Midtbøll Ørnbjerg, Ziga Rotar, Maria Jose Santos, Tanja A Stamm, Simon R Stones, Anja Strangfeld, Sytske Anne Bergstra, Robert B M Landewé, Axel Finckh
EULAR 2021 updated viewpoints on SARS-CoV-2 vaccination in patients with RMDs: a guidance to answer patients’ questions
Johannes WJ Bijlsma
Short-term, intermediate-term and long-term risks of acute coronary syndrome in cohorts of patients with RA starting biologic DMARDs: results from four Nordic countries
Benedicte Delcoigne, Lotta Ljung, Sella A Provan, Bente Glintborg, Merete Lund Hetland, Kathrine Lederballe Grøn, Ritva Peltomaa, Heikki Relas, Carl Turesson, Bjorn Gudbjornsson, Brigitte Michelsen, Johan Askling
Tofacitinib and risk of cardiovascular outcomes: results from the Safety of TofAcitinib in Routine care patients with Rheumatoid Arthritis (STAR-RA) study
Farzin Khosrow-Khavar, Seoyoung C Kim, Hemin Lee, Su Been Lee, Rishi J Desai
Ageing and interferon gamma response drive the phenotype of neutrophils in the inflamed joint
Ricardo Grieshaber-Bouyer, Tarik Exner, Nicolaj S Hackert, Felix A Radtke, Scott A Jelinsky, Olha Halyabar, Alexandra Wactor, Elham Karimizadeh, Joseph Brennan, Jorge Schettini, Helena Jonsson, Deepak A Rao, Lauren A Henderson, Carsten Müller-Tidow, Hanns-Martin Lorenz, Guido Wabnitz, James A Lederer, Angela Hadjipanayis, Peter A Nigrovic
Efficacy and safety of selective TYK2 inhibitor, deucravacitinib, in a phase II trial in psoriatic arthritis
Philip J Mease, Atul A Deodhar, Désirée van der Heijde, Frank Behrens, Alan J Kivitz, Jeffrey Neal, Jonghyeon Kim, Shalabh Singhal, Miroslawa Nowak, Subhashis Banerjee
Persistence and effectiveness of the IL-12/23 pathway inhibitor ustekinumab or tumour necrosis factor inhibitor treatment in patients with psoriatic arthritis: 1-year results from the real-world PsABio Study
Laure Gossec, Stefan Siebert, Paul Bergmans, Kurt de Vlam, Elisa Gremese, BeatrÃz Joven-Ibáñez, Tatiana V Korotaeva, Frederic Lavie, Wim Noël, Michael T Nurmohamed, Petros P Sfikakis, Elke Theander, Josef S Smolen
Factors predicting axial spondyloarthritis among first-degree relatives of probands with ankylosing spondylitis: a family study spanning 35 years
Sjef M van der Linden, Muhammad Asim Khan, Zhixiu Li, Heinz Baumberger, Hermine van Zandwijk, Kazim Khan, Peter M Villiger, Matthew A Brown
Tocilizumab in patients with new onset polymyalgia rheumatica (PMR-SPARE): a phase 2/3 randomised controlled trial
Michael Bonelli, Helga Radner, Andreas Kerschbaumer, Daniel Mrak, Martina Durechova, Jutta Stieger, Rusmir Husic, Peter Mandl, Josef S Smolen, Christian Dejaco, Daniel Aletaha
Immune cell multiomics analysis reveals contribution of oxidative phosphorylation to B-cell functions and organ damage of lupus
Yusuke Takeshima, Yukiko Iwasaki, Masahiro Nakano, Yuta Narushima, Mineto Ota, Yasuo Nagafuchi, Shuji Sumitomo, Tomohisa Okamura, Keith Elkon, Kazuyoshi Ishigaki, Akari Suzuki, Yuta Kochi, Kazuhiko Yamamoto, Keishi Fujio
Peripheral blood gene expression profiling shows predictive significance for response to mycophenolate in systemic sclerosis-related interstitial lung disease
Shervin Assassi, Elizabeth R Volkmann, W Jim Zheng, Xuan Wang, Holly Wilhalme, Marka A Lyons, Michael D Roth, Donald P Tashkin
Baricitinib for relapsing giant cell arteritis: a prospective open-label 52-week pilot study
Matthew J Koster, Cynthia S Crowson, Rachel E Giblon, Jane M Jaquith, Ali Duarte-GarcÃa, Eric L Matteson, Cornelia M Weyand, Kenneth J Warrington
Postvaccination antibody titres predict protection against COVID-19 in patients with autoimmune diseases: survival analysis in a prospective cohort
Sakir Ahmed, Pankti Mehta, Aby Paul, S Anu, Somy Cherian, Veena Shenoy, Kaveri K Nalianda, Sanjana Joseph, Anagha Poulose, Padmanabha Shenoy
Efficacy of COVID-19 vaccines in patients taking immunosuppressants
Chen Shen, Malcolm Risk, Elena Schiopu, Salim S Hayek, Tiankai Xie, Lynn Holevinski, Cem Akin, Gary Freed, Lili Zhao
Pausing methotrexate improves immunogenicity of COVID-19 vaccination in elderly patients with rheumatic diseases
Amanthi Nadira Arumahandi de Silva, Leonie Maria Frommert, Fredrik N Albach, Jens Klotsche, Veronika Scholz, Lara Maria Jeworowski, Tatjana Schwarz, Alexander ten Hagen, Jan Zernicke, Victor Max Corman, Christian Drosten, Gerd-Rüdiger Burmester, Robert Biesen
Two-week methotrexate discontinuation in patients with rheumatoid arthritis vaccinated with inactivated SARS-CoV-2 vaccine: a randomised clinical trial
Carlo Scognamiglio Renner Araujo, Ana Cristina Medeiros-Ribeiro, Carla G S Saad, Karina Rossi Bonfiglioli, Diogo Souza Domiciano, Andrea Yukie Shimabuco, Matheus Santos Rodrigues Silva, Emily Figueiredo Neves Yuki, Sandra Gofinet Pasoto, Tatiana Pedrosa, Leonard de Vinci Kanda Kupa, Gioanna Zou, Rosa M R Pereira, Clóvis Artur Silva, Nádia Emi Aikawa, Eloisa Bonfa
Has the gout epidemic peaked in the UK? A nationwide cohort study using data from the Clinical Practice Research Datalink, from 1997 to across the COVID-19 pandemic in 2021
Abhishek Abhishek, Laila J Tata, Mamas Mamas, Anthony J Avery
Effectiveness and safety of combined biological therapy in patients with refractory multidomain spondyloarthritis
Cristina Valero, Juan Pablo Baldivieso, Isidoro Gonzalez-Alvaro, Eva Tomero, Santos Castañeda, Rosario GarcÃa-Vicuña
Serum interferon-α levels and IFN type I-stimulated genes score perform equally to assess systemic lupus erythematosus disease activity
François Chasset, Alexis Mathian, Karim Dorgham, Camillo Ribi, Marten Trendelenburg, Uyen Huynh-Do, Pascale Roux-Lombard, Delphine Sophie Courvoisier, Zahir Amoura, Guy Gorochov, Carlo Chizzolini
ADAMTS5 as a therapeutic target for osteoarthritis: Mendelian randomisation study
Sizheng Steven Zhao, Ville Karhunen, Andrew P Morris, Dipender Gill
Error in the dosage of Methotrexate in the EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis
Dennis Scheicht
Response to: ‘Error in the dosage of methotrexate in the EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis’ by Scheicht
Chetan B Mukhtyar, Bernhard Hellmich
Off-label use of tofacitinib: a potential treatment option for SAPHO syndrome
Wenhui Xie, Hong Huang, Zhuoli Zhang
Response to: ‘Off-label use of tofacitinib: a potential treatment option for SAPHO syndrome’ by Xie et al
Yueting Li, Yihan Cao, Chen Li, Wen Zhang
Comment on ‘Successful remission with tofacitinib in a patient with refractory Takayasu arteritis complicated by ulcerative colitis’ by Kuwabara et al
Valeria Rios Rodriguez, Judith Rademacher, Mikhail Protopopov, Murat Torgutalp, Hildrun Haibel, Janis Lucas Vahldiek, Ann-Christin von Brünneck, Safwan Omran, Denis Poddubnyy, Fabian Proft
Response to: ‘Comment on ‘Successful remission with tofacitinib in a patient with refractory Takayasu arteritis complicated by ulcerative colitis’ by Kuwabara et al’ by Rios Rodriguez et al
Shun Tanimura, Hiroyuki Nakamura, Tetsuya Horita
Bowman’s capsule rupture on renal biopsy improves the outcome prediction of ANCA-associated glomerulonephritis classifications
Vincenzo L'Imperio, Gisella Vischini, Fabio Pagni, Pietro Manuel Ferraro
Response to: ‘Bowman's capsule rupture on renal biopsy improves the outcome prediction of ANCA-associated glomerulonephritis classifications’ by L'Imperio et al
Dilek Solmaz, Servet Akar
Pisotriquetral arthritis: ‘forgotten’ joint in ultrasound imaging of the wrist
Andrea Becciolini, Alarico Ariani, Marco Becciolini
Response to: ‘Pisotriquetral arthritis: ‘forgotten’ joint in ultrasound imaging of the wrist’ by Becciolini et al
Andrea Di Matteo, Kulveer Mankia, Richard J Wakefield, Paul Emery
Comparison of MS score and HScore for the diagnosis of adult-onset Still’s disease-associated macrophage activation syndrome
Lei Zhang, Xiaopei Yang, Tian-Fang Li, Xiaojun Liu, Shengyun Liu
Response to: ‘Comparison of MS score and HScore for the diagnosis of adult-onset Still’s disease associated macrophage activation syndrome’ by Zhang et al
Francesca Minoia, Angelo Ravelli
Understanding bone fragility: theoretical explanation to non-physician health professionals
Toshihiro Sugiyama
Response to: ‘Understanding bone fragility: theoretical explanation to non-physician health professionals’ by Sugiyama
Jo Adams, Nicky Wilson, Tanja A Stamm
Changing the outcome measures, changing the results? The urgent need of a specific disease activity score to adult-onset Still’s disease
Piero Ruscitti, Tanja A Stamm, Roberto Giacomelli
Response to: ‘Changing the outcome measures, changing the results? The urgent need of a specific Disease Activity Score to adult-onset Still’s disease’ by Ruscitti et al
Claudia Kedor, Joachim Listing, Jan Zernicke, Eugen Feist
Diagnostic accuracy of novel ultrasonographic halo score for giant cell arteritis: methodological issues
Hadis Ghajari, Siamak Sabour
Response to: ‘Diagnostic accuracy of novel ultrasonographic halo score for giant cell arteritis: methodological issues’ by Ghajari and Sabour
Kornelis SM van der Geest, Frances Borg, Abdul Kayani, Davy Paap, Prisca Gondo, Wolfgang Schmidt, Raashid Ahmed Luqmani, Bhaskar Dasgupta
Correspondence to ‘Hypersensitivity reactions with allopurinol and febuxostat: a study using the Medicare claims data’
Kevin Sheng-Kai Ma, James Cheng-Chung Wei, Wen-Hung Chung
Response to: ‘Correspondence to “Hypersensitivity reactions with allopurinol and febuxostat: a study using the Medicare claims data’ by Ma et al
Jasvinder A Singh1,2
Correction: EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis
